Literature DB >> 11328656

Polynucleotide: adenosine glycosidase activity of immunotoxins containing ribosome-inactivating proteins.

L Barbieri1, A Bolognesi, P Valbonesi, L Polito, F Olivieri, F Stirpe.   

Abstract

Polynucleotide:adenosine glycosidases (rRNA N-glycosidases, EC 3.2.2.22, more commonly known as ribosome-inactivating proteins, RIP) are a numerous family of plant and bacterial enzymes, shown to release also adenine from DNA in vitro. They are well suited for the preparation of specifically toxic conjugates with several carriers, including monoclonal antibodies (immunotoxins). Here we show that (i) immunotoxins containing various PNAG (dianthin, gelonin, momordin I, PAP-S, PDS-2, ricin A-chain, saporin-L1, saporin-S6) all act on DNA; (ii) activity on DNA in vitro is less compromised by disulphide linkage to antibody than is inhibition of cell-free protein translation; and (iii) specific cytotoxicity of immunotoxin does not correlate with substrate specificity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11328656     DOI: 10.3109/10611860008997906

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  13 in total

1.  Preparation and antitumor effect of a toxin-linked conjugate targeting vascular endothelial growth factor receptor and urokinase plasminogen activator.

Authors:  Ying Xiang; Qiying Li; Dehong Huang; Xianjun Tang; Li Wang; Yang Shi; Wenjun Zhang; Tao Yang; Chunyan Xiao; Jianghong Wang
Journal:  Exp Biol Med (Maywood)       Date:  2014-08-14

2.  Soapwort Saporin L3 Expression in Yeast, Mutagenesis, and RNA Substrate Specificity.

Authors:  Hongling Yuan; Quan Du; Matthew B Sturm; Vern L Schramm
Journal:  Biochemistry       Date:  2015-07-14       Impact factor: 3.162

3.  Transition state analogues rescue ribosomes from saporin-L1 ribosome inactivating protein.

Authors:  Matthew B Sturm; Peter C Tyler; Gary B Evans; Vern L Schramm
Journal:  Biochemistry       Date:  2009-10-20       Impact factor: 3.162

4.  Expression of CTLA-4 in nonhuman primate lymphocytes and its use as a potential target for specific immunotoxin-mediated apoptosis: results of in vitro studies.

Authors:  G L Palmisano; P L Tazzari; E Cozzi; A Bolognesi; L Polito; M Seveso; E Ancona; F Ricci; R Conte; F Stirpe; G B Ferrara; M P Pistillo
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

Review 5.  Toxin-based therapeutic approaches.

Authors:  Assaf Shapira; Itai Benhar
Journal:  Toxins (Basel)       Date:  2010-10-28       Impact factor: 4.546

Review 6.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

7.  Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells.

Authors:  Letizia Polito; Daniele Mercatelli; Massimo Bortolotti; Stefania Maiello; Alice Djemil; Maria Giulia Battelli; Andrea Bolognesi
Journal:  Toxins (Basel)       Date:  2017-05-30       Impact factor: 4.546

Review 8.  Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview.

Authors:  Letizia Polito; Alice Djemil; Massimo Bortolotti
Journal:  Biomedicines       Date:  2016-06-01

Review 9.  Hyperuricaemia, Xanthine Oxidoreductase and Ribosome-Inactivating Proteins from Plants: The Contributions of Fiorenzo Stirpe to Frontline Research.

Authors:  Andrea Bolognesi; Massimo Bortolotti; Maria Giulia Battelli; Letizia Polito
Journal:  Molecules       Date:  2017-01-27       Impact factor: 4.411

10.  High in Vitro Anti-Tumor Efficacy of Dimeric Rituximab/Saporin-S6 Immunotoxin.

Authors:  Massimo Bortolotti; Andrea Bolognesi; Maria Giulia Battelli; Letizia Polito
Journal:  Toxins (Basel)       Date:  2016-06-21       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.